Crinetics Pharmaceuticals (CRNX) Q3 2024 Earnings
CRNX·Reported November 12, 2024·After market close
Diluted EPS came in at $-0.96, missed the $-0.91 consensus by $0.05.
Diluted EPS
$-0.96missed by $0.05
Consensus: $-0.91
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Crinetics Pharmaceuticals's Q3 2024 earnings report.
Crinetics Pharmaceuticals (CRNX) reported Q3 2024 earnings on November 12, 2024 after market close.
Crinetics Pharmaceuticals reported diluted EPS of $-0.96 for Q3 2024.
EPS missed the consensus estimate of $-0.91 by $0.05.
You can read the 10-Q periodic report (0000950170-24-125420) directly on SEC EDGAR. The filing index links above go to sec.gov.